| Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk AL Sherborne, FJ Hosking, RB Prasad, R Kumar, R Koehler, ... Nature genetics 42 (6), 492-494, 2010 | 310 | 2010 |
| ABCC1 polymorphisms in anthracycline‐induced cardiotoxicity in childhood acute lymphoblastic leukaemia AF Semsei, DJ Erdelyi, I Ungvari, E Csagoly, MZ Hegyi, PS Kiszel, ... Cell biology international 36 (1), 79-86, 2012 | 137 | 2012 |
| Teenagers and young adults with cancer in Europe: from national programmes to a European integrated coordinated project D Stark, S Bielack, L Brugieres, U Dirksen, X Duarte, S Dunn, DJ Erdelyi, ... European Journal of Cancer Care 25 (3), 419-427, 2016 | 103 | 2016 |
| Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia K Csordas, M Hegyi, OT Eipel, J Muller, DJ Erdelyi, GT Kovacs Anti-Cancer Drugs 24 (2), 189-197, 2013 | 81 | 2013 |
| Association of some rare haplotypes and genotype combinations in the MDR1 gene with childhood acute lymphoblastic leukaemia AF Semsei, DJ Erdélyi, I Ungvári, E Kámory, B Csókay, H Andrikovics, ... Leukemia Research 32 (8), 1214-1220, 2008 | 68 | 2008 |
| Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy DJ Erdιlyi, E Kamory, B Csokay, H Andrikovics, A Tordai, C Kiss, ... The pharmacogenomics journal 8 (5), 321-327, 2008 | 65 | 2008 |
| Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance O Lautner-Csorba, A Gézsi, ÁF Semsei, P Antal, DJ Erdélyi, G Schermann, ... BMC medical genomics 5, 1-15, 2012 | 63 | 2012 |
| Roles of genetic polymorphisms in the folate pathway in childhood acute lymphoblastic leukemia evaluated by Bayesian relevance and effect size analysis O Lautner-Csorba, A Gezsi, DJ Erdelyi, G Hullam, P Antal, AF Semsei, ... PloS one 8 (8), e69843, 2013 | 55 | 2013 |
| Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma M Hegyi, A Arany, AF Semsei, K Csordas, O Eipel, A Gezsi, N Kutszegi, ... Oncotarget 8 (6), 9388, 2017 | 46 | 2017 |
| Associations of novel genetic variations in the folate‐related and ARID5B genes with the pharmacokinetics and toxicity of high‐dose methotrexate in paediatric … K Csordas, O Lautner‐Csorba, AF Semsei, A Harnos, M Hegyi, DJ Erdelyi, ... British journal of haematology 166 (3), 410-420, 2014 | 46 | 2014 |
| Isotopic ‘altitude’and ‘continental’effects in modern precipitation across the Adriatic–Pannonian Region Z Kern, IG Hatvani, G Czuppon, I Fórizs, D Erdélyi, T Kanduč, L Palcsu, ... Water 12 (6), 1797, 2020 | 42 | 2020 |
| Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma JC Sági, B Egyed, A Kelemen, N Kutszegi, M Hegyi, A Gézsi, ... BMC cancer 18, 1-14, 2018 | 42 | 2018 |
| Clinical relations of methotrexate pharmacokinetics in the treatment for pediatric osteosarcoma M Hegyi, Á Gulácsi, E Cságoly, K Csordás, OT Eipel, DJ Erdélyi, J Müller, ... Journal of cancer research and clinical oncology 138, 1697-1702, 2012 | 39 | 2012 |
| The role of ABC-transporter gene polymorphisms in chemotherapy induced immunosuppression, a retrospective study in childhood acute lymphoblastic leukaemia DJ Erdélyi, E Kámory, A Zalka, ÁF Semsei, B Csókay, H Andrikovics, ... Cellular immunology 244 (2), 121-124, 2006 | 39 | 2006 |
| HLA-DRB1* 07: 01–HLA-DQA1* 02: 01–HLA-DQB1* 02: 02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia N Kutszegi, X Yang, A Gézsi, G Schermann, DJ Erdélyi, ÁF Semsei, ... haematologica 102 (9), 1578, 2017 | 37 | 2017 |
| Analysis of the spatial distribution of stable oxygen and hydrogen isotopes in precipitation across the Iberian Peninsula IG Hatvani, D Erdélyi, P Vreča, Z Kern Water 12 (2), 481, 2020 | 36 | 2020 |
| Late immune recovery in children treated for malignant diseases GT Kovacs, O Barany, B Schlick, M Csoka, J Gado, A Ponyi, J Müller, ... Pathology & Oncology Research 14, 391-397, 2008 | 36 | 2008 |
| The glucocorticoid receptor gene polymorphism N363S predisposes to more severe toxic side effects during pediatric acute lymphoblastic leukemia (ALL) therapy OT Eipel, K Németh, D Török, K Csordas, M Hegyi, A Ponyi, A Ferenczy, ... International journal of hematology 97, 216-222, 2013 | 31 | 2013 |
| Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia A Rzepiel, N Kutszegi, A Gézsi, JC Sági, B Egyed, G Péter, H Butz, ... Journal of translational medicine 17, 1-16, 2019 | 30 | 2019 |
| MicroRNA-181a as novel liquid biopsy marker of central nervous system involvement in pediatric acute lymphoblastic leukemia B Egyed, N Kutszegi, JC Sági, A Gézsi, A Rzepiel, T Visnovitz, P Lőrincz, ... Journal of Translational Medicine 18, 1-12, 2020 | 24 | 2020 |
